Business
Imagion (ASX:IBX) share price up 1,166% in a year pursuing ‘radiation-free’ cancer tech
The Imagion Biosystems Ltd (ASX: IBX) share price has rocketed 1,166% over the past 12 months due to a series of promising projects around cancer detection.
The company’s bio is truly a mouthful: its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and – the clincher — superparamagnetic relaxometry.
What investors should know is that it develops medical devices focused around cancer screening technology.
Imagion’s Magsense cancer screening technology
One of these tech projects, called Magsense, is a diagnostic imaging tool that can potentially increase…
-
General15 hours agoCitizen Kane’s iconic Rosebud sled sells at auction for more than $22 million
-
Business23 hours agoASX 200 or ASX 300? Here’s the index fund that comes out on top
-
General13 hours agoFormer Russian President Dmitry Medvedev issues warning over Ukraine escalation
-
Noosa News18 hours agoWho was the first PM to visit China? Take the Brisbane Times Quiz